Pegunigalsidase Alfa

ATC A16AB20 · 7 markets · 12 records

Pegunigalsidase Alfa 7 markets · 12 records Forms

AU 3 records · 3 strengths

20 mg/10 mLinjectionELFABRIO also in US·GB
20 mginjectionELFABRIO pegunigalsidase alfa 20 mg/10 mL concentrated injection vial unknown

Records without a stated strength · 1 ELFABRIO

US 2 records · 2 strengths

20 mg/10 mLinjectionELFABRIO also in AU·GB
5 mg/2.5 mLinjectionELFABRIO also in GB

GB 2 records · 2 strengths

20 mg/10 mLinjectionElfabrio 20mg/10ml concentrate for solution for infusion vials also in AU·US
5 mg/2.5 mLinjectionElfabrio 20mg/10ml concentrate for solution for infusion vials also in US

CA 2 records · 1 strengths

2 mg/1 mLliquidELFABRIO

SG 1 records · 1 strengths

2 mg/mLinjectionElfabrio Concentrate for Solution for Infusion 2 mg/ml

TW 1 records · 1 strengths

2 mginjectionElfabrio 2 mg/mL concentrate for solution for infusion+1翡立柏濃縮注射液2毫克/毫升

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 ELFABRIO

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	TW	EU
20 mg/10 mL injection	ELFABRIO	Elfabrio 20mg/10ml concentrate for solution for infusion vials	not recorded	ELFABRIO	not recorded	not recorded	not recorded
5 mg/2.5 mL injection	ELFABRIO	Elfabrio 20mg/10ml concentrate for solution for infusion vials	not recorded	not recorded	not recorded	not recorded	not recorded
2 mg injection	not recorded	not recorded	not recorded	not recorded	not recorded	Elfabrio 2 mg/mL concentrate for solution for infusion 翡立柏濃縮注射液2毫克/毫升	not recorded
2 mg/1 mL liquid	not recorded	not recorded	ELFABRIO	not recorded	not recorded	not recorded	not recorded
20 mg injection	not recorded	not recorded	not recorded	ELFABRIO pegunigalsidase alfa 20 mg/10 mL concentrated injection vial	not recorded	not recorded	not recorded
2 mg/mL injection	not recorded	not recorded	not recorded	not recorded	Elfabrio Concentrate for Solution for Infusion 2 mg/ml	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	ELFABRIO	not recorded	not recorded	ELFABRIO

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

3 more strength/form rows are recorded only in CA · SG · TW and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en CA · SG · TW que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 CA · SG · TW 有记录（未在本表显示）。另有 3 個規格/劑型僅在 CA · SG · TW 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.